Benzinga | Feb 4, 2021 08:01AM EST

Alexion Pharmaceuticals Q4 Adj. EPS $2.96 Beats $2.56 Estimate, Sales $1.59B Beat $1.52B Estimate

Alexion Pharmaceuticals (NASDAQ:ALXN) reported quarterly earnings of $2.96 per share which beat the analyst consensus estimate of $2.56 by 15.62 percent. This is a 9.23 percent increase over earnings of $2.71 per share from the same period last year. The company reported quarterly sales of $1.59 billion which beat the analyst consensus estimate of $1.52 billion by 4.72 percent. This is a 15.01 percent increase over sales of $1.38 billion the same period last year.